Author-year | Age | TNM (stage) | Total dose | Chemotherapy | Menstruation (follow-up period) | Pregnancy |
---|---|---|---|---|---|---|
Tulandi 1998 [16] | 34 | T1bN0M0 | 45Gy/25fr | No | + | +a |
Bisharah 2003 [17] | 28 | NA | 45Gy/25fr | No | + | |
Farber 2005 [18] | 28 | T4aN0M0 | 45Gy/25fr | 5-FU + LV | + | |
Kurt 2007 [19] | 24 | T3N1M0 | 45Gy/25fr | 5-FU + LV | +b | +c |
Elizur 2009 [20] | 28 | T3N1M0 | NA | No | NA | |
29 | T3N1M0 | 5-FU | +d | |||
33 | T1NxMx | 5-FU | ||||
34 | T3cN1M0 | 5-FU | ||||
38 | T3N0M0 | 5-FU | ||||
Al-Badawi 2010 [21] | 23 | T3N1M0 | NA | No | Lost (10 months) | |
23 | TXN1M0 | No | + (60 months) | |||
26 | T3N1M0 | No | + (46 months) | |||
28 | T3N1M0 | No | Lost (12 months) | |||
Gareer 2011 [22] | 15 | + | ||||
17 | + | |||||
(Needle oophoropexy) | 19 | + | ||||
20 | + | 3 of 10 achieved pregnancy | ||||
25 | NA | NA | NA | + | ||
26 | + | |||||
26 | Lost | |||||
30 | + | |||||
31 | + | |||||
33 | + | |||||
Al-Asari 2012 [23] | 21 | Two of three maintained their menstruatione | ||||
21-27 | NA | NA | NA | |||
27 | ||||||
Barahmeh 2013 [24] | 33 | cT3N1M0 | 50.4Gy/28fr | 5-FU | Lost | |
NA | NA | + | ||||
NA | NA | + | ||||
NA | NA | + | ||||
Present case | 14 | pT3N1bM0 | 50.4Gy/28fr | 5-FU + OX | + (24 months) |